DE69617005T2 - 2-amino-benzoxazinone zur behandlung von viralen infektionen - Google Patents

2-amino-benzoxazinone zur behandlung von viralen infektionen

Info

Publication number
DE69617005T2
DE69617005T2 DE69617005T DE69617005T DE69617005T2 DE 69617005 T2 DE69617005 T2 DE 69617005T2 DE 69617005 T DE69617005 T DE 69617005T DE 69617005 T DE69617005 T DE 69617005T DE 69617005 T2 DE69617005 T2 DE 69617005T2
Authority
DE
Germany
Prior art keywords
viral infections
benzoxazinone
amino
treating viral
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69617005T
Other languages
English (en)
Other versions
DE69617005D1 (de
Inventor
Norman Abood
L Flynn
P Becker
M Bax
Hui Li
A Nosal
A Schretzman
I Villamil
J Bennett
L Bedell
Kenneth Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Priority claimed from US09/502,038 external-priority patent/US6380189B1/en
Publication of DE69617005D1 publication Critical patent/DE69617005D1/de
Application granted granted Critical
Publication of DE69617005T2 publication Critical patent/DE69617005T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69617005T 1995-05-24 1996-05-23 2-amino-benzoxazinone zur behandlung von viralen infektionen Expired - Fee Related DE69617005T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/448,795 US5985872A (en) 1995-05-24 1995-05-24 2-amino-benzoxazinones for the treatment of viral infections
PCT/US1996/007526 WO1996037485A1 (en) 1995-05-24 1996-05-23 2-amino-benzoxazinones for the treatment of viral infections
US95262498A 1998-05-15 1998-05-15
US09/502,038 US6380189B1 (en) 1995-05-24 2000-02-11 2-amino benzoxazinones for the treatment of viral infections
US10/035,433 US6683077B2 (en) 1995-05-24 2002-01-04 2-Amino-benzoxazinones for the treatment of viral infections

Publications (2)

Publication Number Publication Date
DE69617005D1 DE69617005D1 (de) 2001-12-20
DE69617005T2 true DE69617005T2 (de) 2002-07-04

Family

ID=37772666

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69632876T Expired - Fee Related DE69632876T2 (de) 1995-05-24 1996-05-23 2-Amino-Benzoxazinone zur Behandlung von viralen Infektionen
DE69617005T Expired - Fee Related DE69617005T2 (de) 1995-05-24 1996-05-23 2-amino-benzoxazinone zur behandlung von viralen infektionen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69632876T Expired - Fee Related DE69632876T2 (de) 1995-05-24 1996-05-23 2-Amino-Benzoxazinone zur Behandlung von viralen Infektionen

Country Status (15)

Country Link
US (3) US5985872A (de)
EP (1) EP0828721B1 (de)
JP (1) JPH11505849A (de)
CN (1) CN1070480C (de)
AT (2) ATE208765T1 (de)
AU (1) AU711174B2 (de)
BR (1) BR9608506A (de)
CA (1) CA2222034A1 (de)
DE (2) DE69632876T2 (de)
DK (1) DK0828721T3 (de)
ES (2) ES2225339T3 (de)
NZ (1) NZ308398A (de)
PT (2) PT1122245E (de)
TW (1) TW455583B (de)
WO (1) WO1996037485A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100460932B1 (ko) * 1995-05-24 2005-02-28 지.디. 썰 엘엘씨 바이러스감염치료용2-아미노-벤조옥사진온
US5985872A (en) 1995-05-24 1999-11-16 G.D. Searle & Co. 2-amino-benzoxazinones for the treatment of viral infections
WO1997048707A1 (en) * 1996-06-20 1997-12-24 Smithkline Beecham Plc 4h-3,1-benzoxazin-4-one derivatives and analogs as antiviral agents
GB9710928D0 (en) * 1997-05-29 1997-07-23 Smithkline Beecham Plc Pharmaceuticals
AR022204A1 (es) * 1999-01-08 2002-09-04 Norgine Bv Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende.
GB9900416D0 (en) * 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
MXPA02000485A (es) * 1999-07-12 2004-09-10 Searle & Co 2-amino-benzoxazinonas para el tratamiento del virus de herpes simple.
US6806269B1 (en) * 1999-07-12 2004-10-19 G. D. Searle & Cop 2-Amino-benzoxazinones for the treatment of herpes simplex virus
DE10036184A1 (de) * 2000-07-24 2002-02-14 Aventis Cropscience Gmbh Substituierte Sulfonylaminomethylbenzoesäure(derivate) und Verfahren zu ihrer Herstellung
EP1403269A1 (de) * 2001-06-13 2004-03-31 Asahi Kasei Pharma Corporation Heilmittel für infektiöse virenerkrankung
ATE431335T1 (de) * 2002-11-21 2009-05-15 Neurosearch As Diarylureidoderivate und deren medizinische verwendung
US7192471B2 (en) * 2004-09-24 2007-03-20 Honeywell International Inc. Aryl-ureido benzoxazinone compounds
BRPI0718988A2 (pt) 2006-11-22 2014-02-11 Ajinomoto Kk Método para preparar um derivado de fenilalanina, e, composto
JP2010525069A (ja) * 2007-04-27 2010-07-22 パラテック ファーマシューティカルズ インコーポレイテッド アミノアルキルテトラサイクリン化合物の合成方法および精製方法
US8356971B2 (en) * 2009-12-17 2013-01-22 Detch John W Disc turbine with streamlined hub vanes and co-axial exhaust tube
CN115109006A (zh) * 2022-05-20 2022-09-27 上海大学 一种3-取代-1,2-苯并噁嗪-4-酮类化合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297755A (en) * 1960-12-02 1967-01-10 Hoffmann La Roche 2-chloro-5-trifluoromethylbenzo-phenone compounds
US3450700A (en) * 1966-12-20 1969-06-17 Upjohn Co 2-tertiary amino-4h-3,1-benzoxazin-4-ones
DE2218302A1 (de) * 1972-04-15 1973-10-25 Bayer Ag Verfahren zur herstellung von trifluormethylimino-derivaten von benzoxazinonen
DE2315303A1 (de) * 1973-03-27 1974-10-17 Bayer Ag Verfahren zur herstellung von n-substituierten 2-amino-3,1-benzoxazin-4-onen
NZ210669A (en) * 1983-12-27 1988-05-30 Syntex Inc Benzoxazin-4-one derivatives and pharmaceutical compositions
US4657893A (en) * 1984-05-09 1987-04-14 Syntex (U.S.A.) Inc. 4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors
US4745116A (en) * 1985-06-25 1988-05-17 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and related compounds and pharmaceutical use
US4665070A (en) * 1985-06-25 1987-05-12 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use
CA1309556C (en) * 1987-06-09 1992-10-27 Masayuki Kokubo 4h-3,1-benzoxazin-4-one compounds and pharmaceutical composition thereoffor the inhibition of serine proteases
AU635403B2 (en) * 1990-02-15 1993-03-18 Teijin Limited 4h-3,1-benzoxazin-4-one compound and elastase inhibitor composition containing the same
KR930700494A (ko) * 1990-04-10 1993-03-15 시게루 미즈노 신규한 옥사디논 유도체
NZ242739A (en) * 1991-05-24 1994-12-22 Arch Dev Corp Identification and purification of herpes protease nucleic acid segments and their use in the production of this protease
US5434074A (en) * 1991-07-05 1995-07-18 Gibson; D. Wade Cytomegalovirus proteinase
US5428021A (en) * 1994-01-27 1995-06-27 Sri International Human leukocyte elastase (HLE) inhibitors, and related pharmaceutical compositions and methods of use
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
KR100460932B1 (ko) * 1995-05-24 2005-02-28 지.디. 썰 엘엘씨 바이러스감염치료용2-아미노-벤조옥사진온
US5985872A (en) 1995-05-24 1999-11-16 G.D. Searle & Co. 2-amino-benzoxazinones for the treatment of viral infections

Also Published As

Publication number Publication date
JPH11505849A (ja) 1999-05-25
AU711174B2 (en) 1999-10-07
DE69632876D1 (de) 2004-08-12
NZ308398A (en) 1999-06-29
PT828721E (pt) 2002-04-29
EP0828721A1 (de) 1998-03-18
ATE270667T1 (de) 2004-07-15
DK0828721T3 (da) 2002-03-04
CA2222034A1 (en) 1996-11-28
ATE208765T1 (de) 2001-11-15
DE69617005D1 (de) 2001-12-20
US20030022895A1 (en) 2003-01-30
ES2225339T3 (es) 2005-03-16
DE69632876T2 (de) 2005-03-03
CN1070480C (zh) 2001-09-05
CN1190963A (zh) 1998-08-19
PT1122245E (pt) 2004-11-30
US6683077B2 (en) 2004-01-27
US5985872A (en) 1999-11-16
BR9608506A (pt) 1999-06-15
EP0828721B1 (de) 2001-11-14
TW455583B (en) 2001-09-21
WO1996037485A1 (en) 1996-11-28
US20050032793A1 (en) 2005-02-10
ES2169242T3 (es) 2002-07-01
AU5803096A (en) 1996-12-11

Similar Documents

Publication Publication Date Title
DE69528273D1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
DE69617005T2 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
NO20003233L (no) 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
ATE206409T1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h- benzo(b)(1,5)-diazepin-3-yl)-acetamide
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
ATE229945T1 (de) Zur behandlung von cmv infektionen geeignete 1,3, 4-thiadiazole
EA199901016A1 (ru) 9-оксим-производные эритромицина
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
DK0903347T3 (da) Hidtil ukendte cyclodepsipeptid PF1022-derivater
ATE256667T1 (de) Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen
ES2151168T3 (es) N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
MX9709016A (es) 2-amino-benzoxazinonas, composiciones que las contienen y uso de las mismas.
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
EA200001065A1 (ru) Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
RU95113440A (ru) Ацетамидные и аминоэтантиольные производные, средство и способ лечения пептической язвы или гастрита

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee